YHYuying Huang

Yuying Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yuying Huang has a total of 48 co-authors. Here are the top co-authors by number of shared publications:

  • Bing Sun

    Key Laboratory of Multi-Cell Systems, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China

    4 shared publications
  • Lin Zhu

    Key Laboratory of Multi-Cell Systems, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences; University of Chinese Academy of Sciences, 320 Yueyang Road, Shanghai, China

    4 shared publications
  • Guochao Shi

    Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    3 shared publications
  • Liyan Ma

    Key Laboratory of Multi-Cell Systems, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China

    3 shared publications
  • Shufen Zhong

    Key Laboratory of Multi-Cell Systems, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China

    3 shared publications
  • Siying Sun

    Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

    3 shared publications

Latest Publications

  • Open Access

    ILC2-intrinsic IL-33 amplifies ILC2 activation and allergic lung inflammation

    by Shufen Zhong, Liming Sun, Jinxin Qiu, Bo Peng, Siying Sun, Lin Zhu, Yuying Huang, Shuangfeng Chen, Huacheng Yan, Yutong Guo, et al.

    Interleukin-33 (IL-33) from lung epithelial cells serves as a crucial alarmin to activate the lung-resident group 2 innate lymphoid cells (ILC2s) and then to initiate type 2 inflammation. However, whether IL-33 has an intrinsic role in the ILC2-driven lung inflammation remains unclear. In this study, we characterize the proteomic features of mouse lung ILC2s during activation and observe an increased expression of intrinsic IL-33 in activated ILC2s. The expression of intrinsic IL-33 in lung ILC2s can be induced by the co-stimulation of cysteinyl leukotrienes (CysLTs) and exogenous IL-33. Deletion of ILC2-intrinsic IL-33 attenuates lung inflammation by restraining ILC2 proliferation and cytokine production. Mechanistically, ILC2-intrinsic IL-33 promotes transcriptional activation of both inflammatory and proliferative signaling cascades. Additionally, ILC2-intrinsic IL-33 localizes in the nucleus and promotes the expression of Fosl2 and Nfatc1 through promoting their chromatin accessibility, leading to increased ILC2 proliferation and type 2 cytokine production. Further, we confirm that intrinsic IL-33 can be induced by co-stimulation of CysLTs and exogenous IL-33 in human ILC2s (hILC2s), which is positively related to enhanced hILC2 responses. Collectively, our findings implicate IL-33 as a nuclear factor and intrinsic amplifier of lung-resident ILC2s, operating in a positive feedback loop downstream of exogenous IL-33 and CysLTs co-stimulation to promote allergic lung inflammation.

  • Open Access

    Glutamate attenuates the ILC2 response and allergic airway inflammation via the kainate receptor GluK2

    by Bo Peng, Siying Sun, Lin Zhu, Shufen Zhong, Xixi Chen, Yaguang Zhang, Huacheng Yan, Yidan Sun, Jiajia Lv, Yuying Huang, et al.

    Group 2 innate lymphoid cells (ILC2s) play a critical role in initiating the type 2 immune response, particularly in allergic airway diseases. Although the effects of glutamate on the immune system have been reported previously, its role in modulating the function of ILC2s and lung inflammation remains unclear. In this study, we report that the glutamate levels increased in lung tissue following exposure to allergens. Consequently, glutamate was found to restrain ILC2 responses during lung inflammation in mice. Using Rag1 −/− mice, we demonstrated that the inhibitory effect of glutamate on type 2 inflammation was independent of T and B cells. Further ILC2 adoptive transfer experiments in Rag −/− Il2rg −/− mice confirmed that glutamate likely exerted its effects by directly targeting ILC2s. In vitro experiments revealed that glutamate suppressed ILC2 function through ionic kainate receptor signaling. Genetic deletion of the kainate receptor subunit GluK2 enhanced ILC2 responses and exacerbated type 2 lung inflammation. Mechanistically, transcriptome and metabolic analyses revealed that glutamate reduced oxidative metabolism in ILC2s, thereby limiting their activation. Consistently, in vivo administration of BPAM344—a positive allosteric modulator that potentiates GluK2 signaling—effectively suppressed allergen-induced type 2 inflammation. Notably, ILC2-specific GluK2 deletion markedly attenuated the anti-inflammatory effects of BPAM344, indicating that its protective effects depend on ILC2-intrinsic GluK2 signaling. These findings demonstrate a novel role for glutamate in restraining ILC2 function, as it plays a protective role in alleviating airway inflammation. We propose that GluK2 activation may offer a promising therapeutic strategy for treating ILC2-driven allergic asthma.

  • Acute stress alleviates type 2 lung inflammation by restricting ILC2s through corticosterone-glucocorticoid receptor signaling

    by Lin Zhu, Yuying Huang, Bo Peng, Shufeng Zhong, Xiaoyu Zhang, Fuyang Xiao, Dilare Asim, Jieken Pakezhati, Jinquan Ma, Siying Sun, et al.

    The psychological state profoundly influences immune responses. While chronic stress is generally known to exacerbate inflammation, the impact of acute stress on inflammation has received far less attention. Here, we report that acute stress suppressed group 2 innate lymphoid cell (ILC2) responses, thereby alleviating type 2 lung inflammation. Restraint stress-induced acute stress activated the hypothalamic–pituitary–adrenal (HPA) axis and subsequently increased corticosterone levels. Corticosterone protected mice against lung inflammation by limiting ILC2 proliferation and type 2 cytokine production via the glucocorticoid receptor (GR). Adrenalectomy and genetic perturbation of the GR in ILC2s abolished acute stress-mediated immunosuppressive effects. Mechanistic studies revealed that corticosterone-GR signaling impaired ILC2 responses to microenvironmental factors by dampening downstream NF-κB and JAK-STAT signaling. Collectively, these findings reveal that acute stress alleviates ILC2-mediated lung inflammation through the neuroendocrine circuit and demonstrate the inhibitory role of endogenous corticosterone in ILC2 responses.

  • Open Access

    Solar ultraviolet B radiation promotes α-MSH secretion to attenuate the function of ILC2s via the pituitary–lung axis

    by Yuying Huang, Lin Zhu, Shipeng Cheng, Ranran Dai, Chunrong Huang, Yanyan Song, Bo Peng, Xuezhen Li, Jing Wen, Yi Gong, et al.

    The immunomodulatory effects of ultraviolet B (UVB) radiation in human diseases have been described. Whether type 2 lung inflammation is directly affected by solar ultraviolet (UV) radiation is not fully understood. Here, we show a possible negative correlation between solar UVB radiation and asthmatic inflammation in humans and mice. UVB exposure to the eyes induces hypothalamus-pituitary activation and α-melanocyte-stimulating hormone (α-MSH) accumulation in the serum to suppress allergic airway inflammation by targeting group 2 innate lymphoid cells (ILC2) through the MC5R receptor in mice. The α-MSH/MC5R interaction limits ILC2 function through attenuation of JAK/STAT and NF-κB signaling. Consistently, we observe that the plasma α-MSH concentration is negatively correlated with the number and function of ILC2s in the peripheral blood mononuclear cells (PBMC) of patients with asthma. We provide insights into how solar UVB radiation-driven neuroendocrine α-MSH restricts ILC2-mediated lung inflammation and offer a possible strategy for controlling allergic diseases.